Hospital Universitario Juan Ramon Jimenez — Clinical Trial Site

69 Registered trials

29 Currently recruiting

Organisation

Hospital Universitario Juan Ramon Jimenez

Location

Huelva, Spain

Identifier

ORG-100043674

Address

Ronda Exterior Norte S/n, 21005, Spain

Departments

#3442: Cardiología
2605: Cardiology
3514: Cardiologia
anesthetist
Aparato Digestivo
Cardiology
Cardiology Department
Department of Gastroenterology
Department of Oncology
Digestive
Digestivo
Endocrinología
Endocrinology and Nutrition
Gastroenterology
Hematología
infectious diseases
Internal medicine
Intervensional Cardiology
Medical oncology
Medicina Interna
n/a
neurology
Oncologia
Oncología médica
Oncology
Oncology Service
Pediatría
Physical Medicine and Rehabilitation Service
Pulmonology
Rehabilitation Department
reumathology
Rheumatology
Servicio de Cardiología
Servicio de Digestivo
Servicio de Medicina Interna
Servicio de Neumología
Servicio de Reumatología
Surgery
UCG Enfermedades Infecciosas, Microbiología y Medicina preventiva

Clinical trials at this site (69)

Search interface

A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive… Ended

2023-503568-18-00 Early human epidermal growth factor receptor 2 (HER2) p 5 2021-04-13
A Study to Evaluate Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy Ended

2024-518318-25-00 Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amy 5 2020-06-24
Study to compare the efficacy and safety of NT 201 (botulinum toxin) with placebo for the treatment of lower limb spasticity caused by strok… Ended

2023-505810-12-00 Lower limb spasticity 5 2019-09-03
A phase III multi-center, randomized, open-label trial to evaluate efficacy and safety of ribociclib with endocrine therapy as adjuvant trea… Ended

2023-510357-42-00 hormone receptor (HR)-positive, HER2-negative, early br 5 2019-05-22
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects with Crohn's Disease who Comple… Ended

2023-504951-29-00 Crohn's Disease 5 2017-07-27
A Phase 1b, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Safety, Engraftment, and Initial Signs of Clinical Activity of MB… Ended

2023-507376-50-00 Ulcerative Colitis 1 2024-09-27
Temocilin vs meropenem for the treatment of infections due to Enterobacteriales Ended

2023-508440-21-00 Infections due to Enterobacteriaceae 5 2024-05-21
A proof of concept and dose-finding study of XXB750 in patients with heart failure Ended

2023-504678-39-00 Heart Failure 4 2024-03-13
A Ph3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Severe Hypertriglyceridemia: The ENTRUST study Ended

2023-503576-25-00 Severe Hypertriglyceridemia 5 2023-09-22
The RADIAL study: A clinical trial to learn more about the benefits and the acceptability of trials that include technology to centre the tr… Ended

2022-500449-26-00 Type 2 diabetes mellitus (T2DM) 6 2023-08-03
ABTECT-2 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -2 Ended

2022-500536-11-01 Moderately to severely active ulcerative colitis 5 2023-06-08
Phase II non randomized clinical trial of NIVOLUMAB/IPILIMUMAB maintenance following first-line chemotherapy in unresectable locally advance… Ended

2024-514293-46-00 Unresectable locally advanced or metastatic urothelial 4 2022-07-07
Study to evaluate the efficacy and safety of switching to insulin glargine 300 U/ml from insulin glargine 100 U/ml in patients with type 2 d… Ended

2024-518403-22-00 Diabetes mellitus II 6 2022-06-20
SURVIVAL ANALYSIS AFTER NEOADJUVANT TREATMENT IN RESECTABLE PANCREATIC CANCER WITH RISK FACTORS Ended

2024-519633-35-00 Resectable pancreatic adenocarcinoma with risk factors 6 2021-10-25
Study of Subcutaneous Pembrolizumab versus Intravenous Pembrolizumab, Given with Chemotherapy, to Treat Metastatic Squamous or Non Squamous … Ended

2023-508308-40-00 Metastatic (stage IV) squamous or nonsquamous non-small 5 2021-07-30
A phase III trial of trastuzumab + ALpelisib +/- fulvestrant versus trastuzumab + chemotherapy in patients with PIK3CA mutated previously tr… Ended

2024-514611-98-00 PIK3CA mutated HER2+ advanced or relapsed breast cancer 5 2021-07-20
DTG/3TC vs BIC/FTC/TAF maintenance therapy in people living with HIV: an open-label randomized clinical trial Ended

2024-515167-56-00 HIV 11 2021-06-22
HELIOS-A: A Phase 3 Global Study to Evaluate the Efficacy and Safety of ALN-TTRSC02 in Patients with Hereditary Transthyretin Amyloidosis Ended

2023-508365-33-00 Hereditary Transthyretin Amyloidosis 5 2019-04-09
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negati… Ended

2023-508472-11-00 Patients with early breast cancer 5 2018-06-13
Clinical trial to evaluate the efficacy of intracoronary infusion of autologous bone marrow mononuclear in patients with dilated cardiomyopa… Ended

2024-516594-71-01 Idiopathic dilated cardiomyopathy 4 2013-12-12
CHRONOS - A study to learn about the effects and safety of ODM-111 in participants with long-lasting pain due to osteoarthritis of the knee. Ended

2024-513553-79-00 Chronic Pain due to Ostheoarthritis of the knee 4